Home > Healthcare > Pharmaceuticals > Finished Drug Form > Ophthalmology Drugs Market

Ophthalmology Drugs Market Share

Report ID: GMI6288
Published Date: Jan 2024
Report Format: PDF

Download Free Sample

Ophthalmology Drugs Market Share

The industry leaders operating in this market have established themselves through, continuous research & development, and a strong market presence. Alcon Vision LLC, Bausch Health Companies, Inc., and Bayer AG, account significant market share. These prominent players thrive through a combination of strategic approaches, diverse product portfolio, research and development initiatives, market understanding, and regulatory compliance.

Ophthalmology Drugs Market Companies

Market players operating in the ophthalmology drugs is as mentioned below:

AbbVie, Inc.
Alcon Vision LLC
Bausch Health Companies, Inc.
Bayer AG
Coherus BioSciences
F. Hoffmann-La Roche Ltd.
Novartis AG
Pfizer, Inc.
Regeneron Pharmaceuticals, Inc.
Santen, Inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Ophthalmology drugs industry was worth USD 31 billion in 2023 and is set to exhibit robust 5.1% CAGR from 2024 to 2032 attributed to the rising incidence of eye-related ailments along with increased R&D initiatives.

Prescription segment is poised to witness 5% CAGR between 2024 and 2032 owing to their increasing adoption due to the rise in conditions like AMD and diabetic retinopathy.

North America ophthalmology drugs market is set to expand at 4.8% CAGR from 2024-2032 driven by the significant prevalence of ophthalmic conditions in the region.

Some of the leading ophthalmology drug companies are AbbVie, Inc., Alcon Vision LLC, Bausch Health Companies, Inc., Bayer AG, Coherus BioSciences, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer, Inc., Regeneron Pharmaceuticals, Inc., Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.